Long-Term Assets: The sum of all assets classified as non-current.
Bioventus Inc. (BVS) had Long-Term Assets of $410.72M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$568.09M |
|
$22.73M |
|
$179.93M |
|
$388.16M |
|
$514.11M |
|
$53.98M |
|
$-28.27M |
|
$25.71M |
|
$25.71M |
|
$27.27M |
|
$27.27M |
|
$27.27M |
|
$27.27M |
|
$53.98M |
|
$100.99M |
|
66.62M |
|
68.91M |
|
$0.34 |
|
$0.33 |
|
| Balance Sheet Financials | |
$272.84M |
|
$21.90M |
|
|
Long-Term Assets |
$410.72M |
$683.56M |
|
$160.38M |
|
$278.95M |
|
$294.73M |
|
$455.11M |
|
$228.45M |
|
$-147.43M |
|
$228.45M |
|
82.89M |
|
| Cash Flow Statement Financials | |
$74.67M |
|
$-3.25M |
|
$-62.14M |
|
$41.58M |
|
$51.24M |
|
$9.66M |
|
$12.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.70 |
|
-- |
|
-- |
|
0.55 |
|
1.29 |
|
68.33% |
|
9.50% |
|
9.50% |
|
17.78% |
|
4.53% |
|
4.00% |
|
$72.11M |
|
-- |
|
-- |
|
-- |
|
0.83 |
|
2.19 |
|
4.43 |
|
82.44 |
|
11.94% |
|
-18.50% |
|
3.99% |
|
5.38% |
|
$2.76 |
|
$1.05 |
|
$1.08 |
|